Cite
Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX®‐i120 Platform: A prospective study.
MLA
Wang, Peng‐Xiang, et al. “Circulating Tumor Cell Detection and Single‐cell Analysis Using an Integrated Workflow Based on ChimeraX®‐i120 Platform: A Prospective Study.” Molecular Oncology, vol. 15, no. 9, Sept. 2021, pp. 2345–62. EBSCOhost, https://doi.org/10.1002/1878-0261.12876.
APA
Wang, P., Sun, Y., Jin, W., Cheng, J., Peng, H., Xu, Y., Zhou, K., Chen, L., Huang, K., Wu, S., Hu, B., Zhang, Z., Guo, W., Cao, Y., Zhou, J., Fan, J., & Yang, X. (2021). Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX®‐i120 Platform: A prospective study. Molecular Oncology, 15(9), 2345–2362. https://doi.org/10.1002/1878-0261.12876
Chicago
Wang, Peng‐Xiang, Yun‐Fan Sun, Wei‐Xiang Jin, Jian‐Wen Cheng, Hai‐Xiang Peng, Yang Xu, Kai‐Qian Zhou, et al. 2021. “Circulating Tumor Cell Detection and Single‐cell Analysis Using an Integrated Workflow Based on ChimeraX®‐i120 Platform: A Prospective Study.” Molecular Oncology 15 (9): 2345–62. doi:10.1002/1878-0261.12876.